RetroSearch Browse

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Showing content from https://pubmed.ncbi.nlm.nih.gov/25797632/ below:

Human papillomavirus vaccination of females in a large health claims database in the United States, 2006-2012

doi: 10.1016/j.jadohealth.2015.01.004. Human papillomavirus vaccination of females in a large health claims database in the United States, 2006-2012

Affiliations

¹ National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia. Electronic address: dde9@cdc.gov.
² National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia.

PMID: 25797632
PMCID: PMC5905697
DOI: 10.1016/j.jadohealth.2015.01.004

Item in Clipboard

Human papillomavirus vaccination of females in a large health claims database in the United States, 2006-2012

Eileen F Dunne et al. J Adolesc Health. 2015 Apr.

doi: 10.1016/j.jadohealth.2015.01.004. Affiliations

¹ National Center for HIV, Viral Hepatitis, STD and TB Prevention, CDC, Atlanta, Georgia. Electronic address: dde9@cdc.gov.
² National Center for Immunization and Respiratory Diseases, CDC, Atlanta, Georgia.

PMID: 25797632
PMCID: PMC5905697
DOI: 10.1016/j.jadohealth.2015.01.004

Item in Clipboard

Abstract

Purpose: Information on vaccine utilization from a variety of sources is useful to give a status of the vaccine program and define opportunities to improve uptake. We evaluated MarketScan Commercial Claims and Encounters database on human papillomavirus (HPV) vaccine initiation and completion of all three doses among girls/women from 2006 to 2012.

Methods: Data were obtained from the 2006-2012 MarketScan Commercial Claims and Encounters database. The study population included female enrollees aged 11-26 years who were continuously enrolled in the same private insurance plan from 2006 to 2012 (n = 407,371). We evaluated overall and yearly vaccine initiation and completion, demographic characteristics associated with vaccine initiation, clinical visits in which vaccine was given, and missed opportunities for vaccination.

Results: By the end of 2012, 36.9% of females aged 11-26 years had received at least one HPV vaccine dose. Vaccination coverage was highest among females aged 17-18 years (49.3%) and aged 15-16 years (43.1%) and lowest among females aged 11-12 years (16.8%). Between 2007 and 2012, 96.1% of the 246,192 unvaccinated females had at least one missed opportunity (a heath care visit without HPV vaccine administered).

Conclusions: Over a 6 year period, HPV vaccine initiation was lowest in the girls aged 11-12 years. Importantly, most (96.1%) unvaccinated females had at least one missed vaccination opportunity, and providers and health systems should focus efforts on using existing visits for vaccination.

Keywords: Administrative data; HPV vaccine; Missed opportunities for vaccination; Vaccine coverage.

Published by Elsevier Inc.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: There are no affiliations, financial agreements, or other involvement of any authors with any company whose product figures prominently in this article.

Figures
Figure 1

Type of visit at which…

Figure 1

Type of visit at which first dose of HPV vaccine was administered by…

Figure 1

Type of visit at which first dose of HPV vaccine was administered by age, among females receiving ≥1 dose of HPV vaccine, 2006–2012. *Percentages may not total to 100% due to rounding. *Age as of Dec 31, 2012; 11–12 year cohort was born 2000–2001; 13–14 year cohort was born 1998–1999; 15–16 year cohort was born 1996–1997; 17–18 year cohort was born 1994–1995; 19–26 year cohort was born 1986–1993.